Table 3 Antifungal susceptibility profile of oral Candida isolates from AIDS patients, northwest Ethiopia, 2008/09

All isolates (90)

 Fluconazole

0.125–64

0.25

2

3 (3.3)

11 (12.2)

 Ketoconazole

0.016–16

2

4

-

7 (7.7)

 Itraconazole

0.016–16

0.016

0.063

3 (3.3)

4 (4.7)

 Amphotericin B

0.125– 8

0.125

0.125

-

3 (3.5)

 5-Fuorocytosine

0.125–16

0.125

0.125

-

2 (2.3)

 Micafungin

0.015–8

0.06

1.2

-

2 (2.3)

C. albicans (25)

 Fluconazole

0.125–64

0.25

2

1 (4)

4 (16)

 Ketoconazole

0.016–16

-

3 (12)

 Itraconazole

0.016–16

0.016

0.063

3 (12)

2 (8)

 Amphotericin B

0.125–8

0.5

0.5

-

1 (4)

 5-Fuorocytosine

0.125–16

-

-

-

1 (4)

 Micafungin

0.015–8

-

-

-

1 (4)

C. glabrata (25)

 Fluconazole

0.125–64

0.25

2

1 (6)

3 (8)

 Ketoconazole

0.016–16

-

-

-

1 (4)

 Itraconazole

0.016–16

0.016

0.063

2 (12)

1 (4)

 Amphotericin B

0.125–8

0.5

-

-

-

 5-Fuorocytosine

0.125–16

-

-

-

1 (4)

 Micafungin

0.015–8

-

-

-

-

C. tropicalis (25)

 Fluconazole

0.125–64

0.25

2

-

2 (8)

 Ketoconazole

0.016–16

-

1 (4)

 Itraconazole

0.016–16

0.016

0.063

2 (12)

1 (4)

 Amphotericin B

0.125–8

0.5

0.5

-

-

 5-Fuorocytosine

0.125–16

-

-

-

1 (4)

 Micafungin

0.015–8

-

-

-

-

C. krusei (10)

 Fluconazole

0.125–64

0.25

2

1 (10)

1 (10)

 Ketoconazole

0.016–16

-

-

-

1 (10)

 Itraconazole

0.016–16

0.016

0.063

1 (10)

-

 Amphotericin B

0.125–8

0.5

-

-

-

 5-Fuorocytosine

0.125–16

-

-

-

-

 Micafungin

0.015–8

-

-

-

-

Other Candida species* (5)

 Fluconazole

0.125–64

0.25

2

-

1 (20)

 Ketoconazole

0.016–16

-

-

-

1 (20)

 Itraconazole

0.016–16

0.016

0.063

1 (10)

-

 Amphotericin B

0.125–8

-

-

-

-

 5-Fuorocytosine

0.125–16

-

-

-

-

 Micafungin

0.015–8

-

-

-

-